Table III.
Multivariate logistic regression analysis of characteristics associated with uncontrolled BP at 6 months after dialysis initiation
SBP >90th percentile |
DBP >90th percentile |
+AH medication use at 6 months |
|
---|---|---|---|
OR (95% CI) | OR (95% CI) | OR (95% CI) | |
SBP at 30 days | 1.33 (1.26–1.40) | 1.37 (1.29–1.45) | |
SBP at 6 months | 1.28 (1.18–1.40) | ||
Age at initiation (y) | |||
1 | 0.87 (0.60–1.24) | 2.28 (1.57–3.30) | 0.56 (0.35–0.90) |
2–5 | 0.92 (0.71–1.18) | 1.47 (1.15–1.88) | 0.53 (0.39–0.73) |
6–12 | 0.78 (0.65–0.92) | 1.03 (0.87–1.22) | 1.00 (0.81–1.23) |
≥13 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
Black race | 1.32 (1.11–1.57) | 1.33 (1.12–1.58) | 1.04 (0.84–1.29) |
Female | 0.95 (0.82–1.11) | 1.19 (1.02–1.38) | 0.78 (0.65–0.95) |
Primary disease | |||
Glomerular | 1.26 (1.05–1.52) | 1.51 (1.26–1.82) | 1.62 (1.28–2.04) |
Structural | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
Other | 1.30 (1.05–1.62) | 1.39 (1.12–1.73) | 1.57 (1.20–2.06) |
PD | 0.86 (0.72–1.01) | 1.06 (0.91–1.25) | 0.75 (0.61–0.92) |
+AH medication at 6 months | 1.94 (1.65–2.27) | 1.95 (1.66–2.29) | |
+AH medication at 30 days | 19.78 (16.10–24.30) | ||
Year of dialysis initiation | |||
1992–1995 | 1.31 (1.06–1.64) | 1.51 (1.22–1.88) | 0.70 (0.53–0.92) |
1996–1999 | 1.47 (1.18–1.84) | 1.55 (1.25–1.93) | 0.79 (0.60–1.05) |
2000–2003 | 1.12 (0.89–1.42) | 1.06 (0.84–1.34) | 0.87 (0.65–1.17) |
2004–2008 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |